Eam Global Investors LLC Ocular Therapeutix, Inc Transaction History

Eam Global Investors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 11, 2021	SELL	$15.82 - $22.11 $2.59 Million - $3.62 Million	-163,584 Closed	0 $0
Q4 2020 Feb 11, 2021	SELL	$7.91 - $22.95 $327,339 - $949,739	-41,383 Reduced 20.19%	163,584 $3.39 Million
Q3 2020 Nov 13, 2020	SELL	$7.36 - $9.87 $444,168 - $595,644	-60,349 Reduced 22.75%	204,967 $1.56 Million
Q1 2020 May 13, 2020	BUY	$3.95 - $7.4 $1.05 Million - $1.96 Million	265,316 New	265,316 $1.31 Million

171

138M

150K

225K

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $654M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

Get notified when there are updates to the investment portfolio of Eam Global Investors LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Global Investors LLC with notifications on news.